Thyroid Cancer and Photoacoustic Imaging
Diagnosis of Thyroid Cancer Using Photoacoustic Imaging
1 other identifier
interventional
100
1 country
1
Brief Summary
The aim of this study was to evaluate the usefulness of photoacoustic imaging in thyroid nodules. In addition, we would like to confirm the relationship between the results of photoacoustic imaging and histopathologic findings when thyroid nodules were diagnosed as thyroid cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 28, 2020
CompletedFirst Posted
Study publicly available on registry
January 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedJanuary 30, 2020
January 1, 2020
6 months
January 28, 2020
January 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Photoacoustic analysis of thyroid nodule and thyroid cancer
Photoacoustic intensity of each chromophore (deoxyhemoglobin, oxyhemoglobin, lipid, water) obtained from ROI (region of interest) of photoacoustic image
As soon as the photoacoustic test was performed
Interventions
1. Photoacoustic image of thyroid nodule is obtained by using probe of photoacoustic imaging equipment and image data and data are stored in the device. 2. The patient's examination is the same as the general ultrasound, and the patient is asked to hold his breath for about 3-4 seconds to get the photoacoustic image.
Eligibility Criteria
You may qualify if:
- All thyroid nodule identified as benign or as thyroid cancer
You may not qualify if:
- Patient refuses to participate in the study or withdraws consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul St. Mary's hospital
Seoul, 06591, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 28, 2020
First Posted
January 30, 2020
Study Start
January 1, 2020
Primary Completion
June 30, 2020
Study Completion
December 31, 2020
Last Updated
January 30, 2020
Record last verified: 2020-01